Patient-derived head and neck tumor slice cultures: a versatile tool to study oncolytic virus actionAnnette Runge, Monika Petersson, Marlies C. Glatz et al.|Scientific Reports|2022Cited by 23
Abstract 6658: TcE armed oncolytic virus VSV-GP combines oncolysis and T-cell retargeting for improved efficacyAparna Ponnurangam, Nolden Tobias, Theresa Schwaiger et al.|Cancer Research|2024Cited by 0
An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samplesBenjamin Schoeps, Krishna Das, Stefanie Estermann et al.|Oncogene|2026Cited by 0
Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell responseSabrina Schneider, Tobias Nolden, Theresa Schwaiger et al.|Molecular Therapy Oncology|2026Cited by 0